Betaville

AstraZeneca said to have approached Gilead about $200 billion merger, according to Bloomberg - Part 2

So...there was no statement from AstraZeneca this morning regarding Gilead.

And both the The Times and The Daily Telegraph appear to be poring cold water on the prospect of $200 billion plus merger, which was unveiled yesterday by Bloomberg. Below is the link to The Times report:..

Read more...

AstraZeneca said to have approached Gilead about $200 billion merger, according to Bloomberg

There is a big story breaking on Bloomberg right now about AstraZeneca trying to buy Gilead to create a $200 billion pharmaceutical giant. Below is the link:..

Read more...